APPA

N/A

Report date: 2026/02/26 20:00:22
NME

Base Information

Drug NameAPPA
Drug Alias NameAKL-IVAPPA-1AKL-4APPA
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 modulatorsNuclear factor NF-kappa-B complex modulators
TargetsNuclear factor erythroid 2-related factor 2Nuclear factor NF-kappa-B complex
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmarkUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAKL Research & Development Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAKL Research & Development Ltd
Inactive CompaniesUniversity Of Liverpool
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A